The University of Chicago Header Logo

Connection

Harvey M. Golomb to Carcinoma, Squamous Cell

Back to Details
This is a "connection" page, showing publications Harvey M. Golomb has written about Carcinoma, Squamous Cell.
Harvey M. Golomb
Connection Strength
0.164
Carcinoma, Squamous Cell
  1. Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg. 1985 Mar; 89(3):378-85.
    View in: PubMed
    Score: 0.039
  2. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. Cancer Treat Rep. 1978 Apr; 62(4):567-9.
    View in: PubMed
    Score: 0.024
  3. Adenosquamous lung carcinoma: clinical characteristics, treatment, and prognosis. Ann Thorac Surg. 1987 Nov; 44(5):462-6.
    View in: PubMed
    Score: 0.012
  4. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer. J Thorac Cardiovasc Surg. 1986 Mar; 91(3):344-9.
    View in: PubMed
    Score: 0.010
  5. CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients. Cancer. 1985 Nov 15; 56(10):2385-90.
    View in: PubMed
    Score: 0.010
  6. Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experience. Cancer. 1984 Jul 01; 54(1):5-12.
    View in: PubMed
    Score: 0.009
  7. Non-small cell carcinoma of the lung. Semin Oncol. 1983 Mar; 10(1):1-122.
    View in: PubMed
    Score: 0.008
  8. Chemotherapy of metastatic non-small cell bronchogenic carcinoma. Semin Oncol. 1983 Mar; 10(1):111-22.
    View in: PubMed
    Score: 0.008
  9. Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases. Cancer. 1982 May 01; 49(9):1916-9.
    View in: PubMed
    Score: 0.008
  10. Lung cancer: A combined modality approach to staging and therapy. CA Cancer J Clin. 1979 Sep-Oct; 29(5):258-75.
    View in: PubMed
    Score: 0.007
  11. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP). JAMA. 1978 Dec 15; 240(25):2743-6.
    View in: PubMed
    Score: 0.006
  12. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma. Cancer Treat Rep. 1976 Sep; 60(9):1225-30.
    View in: PubMed
    Score: 0.005
  13. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Cancer J Sci Am. 1995 Nov-Dec; 1(4):288-94.
    View in: PubMed
    Score: 0.005
  14. Large cell carcinoma of the lung. Ultrastructural differentiation and clinicopathologic correlations. Cancer. 1985 Oct 01; 56(7):1618-23.
    View in: PubMed
    Score: 0.003
  15. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach. J Thorac Cardiovasc Surg. 1983 Aug; 86(2):180-5.
    View in: PubMed
    Score: 0.002
  16. Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy. Eur J Cancer Clin Oncol. 1983 Jan; 19(1):33-8.
    View in: PubMed
    Score: 0.002
  17. Bronchogenic carcinoma located in the aortic window. The importance of the primary lesion as a determinant of survival. J Thorac Cardiovasc Surg. 1982 Apr; 83(4):551-62.
    View in: PubMed
    Score: 0.002
  18. Sequential staging in bronchogenic carcinoma. Chest. 1979 Dec; 76(6):653-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.